HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cassandra Kerr Selected Research

5-hydroxymethyluracil

1/20205-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cassandra Kerr Research Topics

Disease

1Leukemia
11/2021
1Hemolysis
01/2021
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2021
1Aplastic Anemia (Anemia, Hypoplastic)
01/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019
1Neoplasms (Cancer)
12/2019

Drug/Important Bio-Agent (IBA)

1Hemoglobins (Hemoglobin)IBA
11/2021
1Complement Factor H (Factor H)IBA
01/2021
1Complement Inactivating AgentsIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
15-hydroxymethyluracilIBA
01/2020
15-formylcytosineIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Biological ProductsIBA
12/2019

Therapy/Procedure

2Therapeutics
01/2020 - 12/2019
1Drug Therapy (Chemotherapy)
12/2019